Immunohistochemical expression of metallothionein in resected hepatic primary tumors and colorectal carcinoma metastases

APMIS

Volumn 107, Issue 4, 1999, Pages 420-424

  Stenram, Unne ^a,b   Ohlsson, Björn ^a   Tranberg, Karl Göran ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fibrolamellar carcinoma; Hepatic tumor; Immunohistochemistry; Metallothionein

Indexed keywords

METALLOTHIONEIN;

ARTICLE; BILE DUCT CARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; HEMANGIOENDOTHELIOSARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TUMOR; MAJOR CLINICAL STUDY; METASTASIS; NODULAR HYPERPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL CARCINOMA;

EID: 0032919927     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01575.x     Document Type: Article

References (17)

1. 1. Bahnson, R. R., Becich, M., Ernstoff, M. S., Sandlow, J., Cohen, M. B. & Williams, R. D.: Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy. J. Urol. 152: 2272-2275, 1994.
2. 2. El Hag, I. A., Ekberg, H., Tranberg, K.-G., Lundstedt, C., Johansson S., Sassner, P. & Hägerstrand, I.: Oncocytic liver tumours and arterial dilatation. Eur. J. Surg. 160: 55-59, 1994.
3. 3. Germain, I., Tetu, B., Brisson, J., Mondor, M. & Cherian, M.G.: Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases. Int. J. Gynecol. Pathol. 15: 54-62, 1996.
4. 4. Giuffrè, G., Barresi, G., Sturniolo, G. C., Sarnelli, R., d'Incà, R. & Tuccari, G.: Immunohistochemical expression of metallothionein in normal human colorectal mucosa, in adenomas and in adenocarcinomas and their associated metastases. Histopathology 29: 347-354, 1996.
5. 5. Janssens, A. R., Bosman F. T., Ruiter, D. J. & Van den Hamer, C. J.: Immunohistochemical demonstration of the cytoplasmic copper-associated protein in the liver in primary biliary cirrhosis: its identification as metallothionein. Liver 4: 139-147, 1984.
6. 6. Jasani, B. & Schmid, K. W.: Significance of metallothionein overexpression in human tumours. Histopathology 31: 211-214, 1997.
7. 7. Kotoh, S., Naito, S., Sakamoto, N., Goto, K. & Kumazawa, J.: Metallothionein expression is correlated with cisplatin resistance in transitional cell carcinoma of the urinary tract. J. Urol. 152: 1267-1270, 1994.
8. 8. Mocchegiani, E., Verbanac, D., Santarelli, L., Tibaldi, A., Muzzioli, M., Radosevic-Stasic, B. & Milin, C.: Zinc and metallothioneins on cellular immune effectiveness during liver regeneration in young and old mice. Life Sci. 61: 1125-1145, 1997.
9. 9. Moffatt, P. & Denizeau, F.: Metallothionein in physiological and physiopathological processes. Drug Metab. Rev. 29: 261-307, 1997.
10. 10. Monden, N., Abe, S., Sutoh, I., Hishikawa, Y., Kinugasa, S. & Naguse, N.: Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-π, and P-glycoprotein in curatively resected gastric cancer. Oncology 54: 391-399, 1997.
11. 11. Nartey, N.O., Frei, J. V. & Cherian, M. G.: Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration). Lab. Invest. 57: 397-401, 1987.
12. 12. Öfner, D., Maier, H., Riedmann, B., Bammer, T., Rumer, A., Winde, G., Bocker, W., Jasani, B. & Schmid, K. W.: Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch. 425: 491-497, 1994.
13. 13. Ohshio, G., Imamura, T., Okada, N., Wang, Z. H., Yamaki, K., Kyogoku, T., Suwa, H., Yamabe, H. & Imamura, M.: Immunohistochemical study of metallothionein in pancreatic carcinomas. J. Cancer Res. Clin. Oncol. 122: 351-355, 1996.
14. 14. Onosaka, S., Min, K.-S., Fukuhara, C., Tanaka, K., Tashiro, S.-I., Shimizu, I., Furuta, M., Yasutomi, T., Kobashi, K. & Yamamoto, K.-I.: Concentrations of metallothionein and metals in malignant and non-malignant tissues in human liver. Toxicology 38: 261-268, 1986.
15. 15. Sato, M. & Bremner, I.: Oxygen free radicals and metallothionein. Free Rad. Biol. Med. 14: 325-337, 1993.
16. 16. Vecchio, F.: Fibrolamellar carcinoma of the liver: a distinct entity within the hepatocellular tumors. A review. Appl. Pathol. 6: 139-148, 1988.
17. 17. Zhang, X. H., Jin, L., Sakamoto, H. & Takenaka, I.: Immunohistochemical localization of metallothionein in human prostate cancer. J. Urol. 156: 1679-1681, 1996.